Medline Inc. (MDLN) stock
MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3066% above fair value
$39.47−0.51 (-1.28%)
Close on Nov 13, 2026Market cap $51.89BP/E –Yield –
Medline operating margin
Operating margin is operating income as a percentage of revenue.
Medline's operating margin for the twelve months ending Sep 26, 2026 was 5.7%. For fiscal 2025 it was 7.8%, against 8.4% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7.8% | −0.6 |
| FY2024 | Dec 31, 2024 | 8.4% | +3.0 |
| FY2023 | Dec 31, 2023 | 5.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | 6.4% | −1.7 |
| Q2 FY2026 | Jun 27, 2026 | 5.1% | −4.2 |
| Q1 FY2026 | Mar 28, 2026 | 5.7% | −2.9 |
| Q4 FY2025 | Dec 31, 2025 | 5.5% | – |
| Q3 FY2025 | Sep 27, 2025 | 8.1% | – |
| Q2 FY2025 | Jun 28, 2025 | 9.3% | – |
| Q1 FY2025 | Mar 29, 2025 | 8.6% | – |
See a number that looks wrong?